In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents

The Establishment of Various Trichomonads of Animals and Man in Axenic Cultures

Diamond, L. S. (1957) · Journal of Parasitology · doi:10.2307/3274682 · Cited by 981

Chemotherapy of Parasitic Diseases

Campbell, W. C., & Rew, R. S. (1986) · Springer eBooks · doi:10.1007/978-1-4684-1233-8 · Cited by 214

Strain of Trichomonas vaginalis Resistant to Metronidazole and Other 5-Nitroimidazoles

Meingassner, J. G., & Thurner, J. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.2.254 · Cited by 148

Metronidazole

Koch‐Weser, J., & Goldman, P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032106 · Cited by 115

Three metronidazole-resistant strains of Trichomonas vaginalis from the United States

Müller, M., Meingassner, J. G., Miller, W. A., & Ledger, W. J. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32741-7 · Cited by 103

Assay Conditions and the Demonstration of Nitroimidazole Resistance in Tritrichomonas foetus

Meingassner, J. G., Mieth, H., Czok, R., Lindmark, D. G., & Müller, M. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.13.1.1 · Cited by 72

Intravenous therapy of metronidazole-resistant Trichomonas vaginalis.

Dombrowski, M. P., Sokol, R. J., Brown, W. J., & Bronsteen, R. A. (1987) · PubMed · Cited by 41

Metronidazole-resistant Trichomonas vaginalis.

Forsgren, A., & Forssman, L. (1979) · Sexually Transmitted Infections · doi:10.1136/sti.55.5.351 · Cited by 36

Studies on strain sensitivity of Trichomonas vaginalis to metronidazole.

Meingassner, J. G., Havelec, L., & Mieth, H. (1978) · Sexually Transmitted Infections · doi:10.1136/sti.54.2.72 · Cited by 27

The incidence of vaginal candida and trichomonas infections and treatment of trichomonas vaginitis with clotrimazole.

Jd, S. (1974) · PubMed · Cited by 23

Metronidazole

Freeman, C. D., Klutman, N. E., & Lamp, K. C. (1997) · Drugs · doi:10.2165/00003495-199754050-00003 · Cited by 489

Treatment of Infections Caused by Metronidazole-ResistantTrichomonas vaginalis

Cudmore, S. L., Delgaty, K. L., Hayward-McClelland, S. F., Petrin, D., & Garber, G. E. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.783-793.2004 · Cited by 310

Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update

Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286

Giardia and Giardiasis

Thompson, R. C. A., Reynoldson, J. A., & Mendis, A. H. W. (1993) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)60207-9 · Cited by 280

Synthesis and antiparasitic activity of 1H-benzimidazole derivatives

Valdez, J., Cedillo, R., Hernández‐Campos, A., Yépez‐Mulia, L., Hernández‐Luis, F., Navarrete‐Vázquez, G., Tapia‐Contreras, A., Cortés-Zárate, R., Hernández, M., & Castillo, R. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00346-3 · Cited by 269

Synthesis and antiparasitic activity of 2-(Trifluoromethyl)benzimidazole derivatives

Navarrete‐Vázquez, G., Cedillo, R., Hernández‐Campos, A., Yépez‐Mulia, L., Hernández‐Luis, F., Valdez, J., Morales, R., Cortés-Zárate, R., Hernández, M., & Castillo, R. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00619-3 · Cited by 210

Tinidazole Therapy for Metronidazole‐Resistant Vaginal Trichomoniasis

Sobel, J. D., Nyirjesy, P., & Brown, W. J. (2001) · Clinical Infectious Diseases · doi:10.1086/323034 · Cited by 169

Tinidazole: A nitroimidazole antiprotozoal agent

Fung, H. B., & Doan, T.-L. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.12.012 · Cited by 160

Strategies for Prevention and Treatment of Trichomonas vaginalis Infections

Bouchemal, K., Bories, C., & Loiseau, P. M. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-16 · Cited by 146

In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis

Narcisi, E. M., & Secor, W. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1121 · Cited by 116

Synthesis and antiparasitic activity of albendazole and mebendazole analogues

Navarrete‐Vázquez, G., Yépez‐Mulia, L., Hernández‐Campos, A., Tapia‐Contreras, A., Hernández‐Luis, F., Cedillo, R., González, J., Martínez‐Fernández, A. R., Martı́nez-Grueiro, M., & Castillo, R. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00497-8 · Cited by 97

The Phylogeny and Biological Function of Gastric Juice—Microbiological Consequences of Removing Gastric Acid

Martinsen, T. C., Fossmark, R., & Waldum, H. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236031 · Cited by 96

Albendazole: a more effective antigiardial agent in vitro than metronidazole or tinidazole

Meloni, B. P., Thompson, R. C. A., Reynoldson, J. A., & Seville, P. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90324-8 · Cited by 81

Synthesis and antiprotozoal activity of novel 1-methylbenzimidazole derivatives

Valdez-Padilla, D., Rodríguez‐Morales, S., Hernández‐Campos, A., Hernández‐Luis, F., Yépez‐Mulia, L., Tapia‐Contreras, A., & Castillo, R. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.059 · Cited by 73

Difficult‐to‐Treat Trichomoniasis: Results with Paromomycin Cream

Nyirjesy, P., Sobel, J. D., Weitz, M. V., Leaman, D., & Gelone, S. P. (1998) · Clinical Infectious Diseases · doi:10.1086/513951 · Cited by 73

Drug resistance in Giardia intestinalis

Upcroft, J., Upcroft, P., & Boreham, P. F. L. (1990) · International Journal for Parasitology · doi:10.1016/0020-7519(90)90196-t · Cited by 69

Trichomoniasis and its treatment

Nanda, N., Michel, R. G., Kurdgelashvili, G., & Wendel, K. A. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.125 · Cited by 63

Trichomonas gallinae in budgerigars and columbid birds in Perth, Western Australia

MCKEON, T., Dunsmore, J. D., & Raidal, S. (1997) · Australian Veterinary Journal · doi:10.1111/j.1751-0813.1997.tb15363.x · Cited by 48

Antiprotozoal activity of proton-pump inhibitors

Pérez‐Villanueva, J., Romo‐Mancillas, A., Hernández‐Campos, A., Yépez‐Mulia, L., Hernández‐Luis, F., & Castillo, R. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.028 · Cited by 45

Quinacrine-resistantGiardia duodenalis

Upcroft, J., Campbell, R. W., & Upcroft, P. (1996) · Parasitology · doi:10.1017/s0031182000065823 · Cited by 45

Chemotherapeutic options for the treatment of human trichomoniasis

Küng, E., Fürnkranz, U., & Walochnik, J. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.10.016 · Cited by 37

Efficient synthesis of 2-(pyrazol-3-yl)benzimidazoles from 3-arylacylidene-3,4-dihydroquinoxalin-2(1H)-ones and hydrazine hydrate via a novel rearrangement

Mamedov, V. A., Murtazina, A. M., Gubaidullin, A. T., Хафизова, Е. А., & Rizvanov, I. K. (2009) · Tetrahedron Letters · doi:10.1016/j.tetlet.2009.05.116 · Cited by 35

Sexually Transmitted Parasitic Diseases

Levine, G. I. (1991) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)00918-0 · Cited by 34

Synthesis and antiprotozoal activity of nitazoxanide–N-methylbenzimidazole hybrids

Soria‐Arteche, O., Hernández‐Campos, A., Yépez‐Mulia, L., Trejo–Soto, P. J., Hernández‐Luis, F., Gres-Molina, J., Maldonado, L. A., & Castillo, R. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.011 · Cited by 33

Enhanced antiparasitic activity of lipophilic tetracyclines: role of uptake

Katiyar, S. K., & Edlind, T. D. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2198 · Cited by 33

Albendazole as a future antigiardial agent

Reynoldson, J. A., Thompson, R. C. A., & Horton, R. J. (1992) · Parasitology Today · doi:10.1016/0169-4758(92)90193-6 · Cited by 33

A versatile one-step method for the synthesis of benzimidazoles from quinoxalinones and arylenediamines via a novel rearrangement

Mamedov, V. A., Saifina, D. F., Rizvanov, I. K., & Gubaidullin, A. T. (2008) · Tetrahedron Letters · doi:10.1016/j.tetlet.2008.05.060 · Cited by 29

Validation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis

Natto, M. J., Savioli, F., Quashie, N. B., Dardonville, C. Y., Rodenko, B., & de Koning, H. P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr572 · Cited by 26

Effects of three benzimidazoles on growth, general morphology and ultrastructure ofTritrichomonas foetus

Carvalho, K. P., & Gadelha, A. P. R. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00897.x · Cited by 25

Mebendazole in parasitic infections other than those caused by soil-transmitted helminths

Cañete, R., Escobedo, A. A., Almirall, P., González, M. E., Brito, K., & Cimerman, S. (2009) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.11.029 · Cited by 22

Different Drugs, Same End: Ultrastructural Hallmarks of Autophagy in Pathogenic Protozoa

Pedra-Rezende, Y., Macedo, I. S., Midlej, V. D. V. P., Mariante, R. M., & Menna‐Barreto, R. F. S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.856686 · Cited by 17

Egg-Shell Like Hollow Alumina Sphere Modified Electrode for Enhanced Electrochemical Determination of Metronidazole

Kalaiyarasi, J., & Pandian, K. (2019) · Journal of The Electrochemical Society · doi:10.1149/2.1211912jes · Cited by 17

Failure of mebendazole to cure trichomonal vaginitis resistant to metronidazole: case reports.

Pattman, R. S., Sprott, M. S., Kearns, A. M., & Earnshaw, M. (1989) · Sexually Transmitted Infections · doi:10.1136/sti.65.4.274 · Cited by 15

TriTOX: A novel Trichomonas vaginalis assay platform for high-throughput screening of compound libraries

Lam, A. Y. F., Vuong, D., Jex, A. R., Piggott, A. M., Lacey, E., & Emery‐Corbin, S. J. (2021) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2021.01.001 · Cited by 14

[Tinidazole: a classical anaerobical drug with multiple potential uses nowadays].

Martínez, J. J. G., Pía Rodicio, M., Matienzo, F. J. M., & Giménez, M.-J. (2009) · PubMed · Cited by 14

Trichomonas vaginalis: tratamiento y resistencia a nitroimidazoles

Vázquez, F., García, M. J. V., Pérez, F., & Palacio, V. (2001) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(01)72580-3 · Cited by 14

Pyrrolidine-based hybrid compounds: design, synthesis, in vitro and in vivo pharmacological properties and molecular docking studies

Taş, S., Döndaş, H. A., Döndaş, N. Y., Poyraz, S., Taşkın‐Tok, T., Demiray, G. A., Belveren, S., İnce, T., Demir, Y., Yılmaz, M. B., et al. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2559573 · Cited by 13

Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasis

Fernando, H. V., Chan, L. L., Dang, N., Santhanes, D., Banneheke, H., Nalliah, S., & Coombes, A. G. A. (2018) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2018.1481430 · Cited by 13

Proton Pump Inhibitor Use Is Associated With a Reduced Risk of Infection with Intestinal Protozoa

Sheele, J. M. (2017) · Wilderness and Environmental Medicine · doi:10.1016/j.wem.2017.06.008 · Cited by 12

Benzimidazoles and related heterocycles 10. A novel acid-catalyzed rearrangement in the system 3-(α-aminobenzyl)quinoxalin-2(1H)-one-ethyl acetoacetate as a simple and efficient method for synthesizing 2-(pyrrol-3-yl)benzimidazoles

Mamedov, V. A., Хафизова, Е. А., Gubaidullin, A. T., Murtazina, A. M., Adgamova, D. I., Samigullina, A. I., & Litvinov, I. А. (2011) · Russian Chemical Bulletin · doi:10.1007/s11172-011-0059-1 · Cited by 12

Effects of antimicrobial agents on growth and chemotaxis of Trichomonas vaginalis

Sugarman, B., & Mummaw, N. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.9.1323 · Cited by 12

Trichomoniasis as Seen in a Chronic Vaginitis Clinic

Dan, M., & Sobel, J. D. (1996) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1002/(sici)1098-0997(1996)4:2 · Cited by 12

Clearance of Mycoplasma genitalium and Trichomonas vaginalis Among Adolescents and Young Adults With Pelvic Inflammatory Disease: Results From the Tech-N Study

Trent, M., Yusuf, H. E., Perin, J., Anders, J., Chung, S.-E., Tabacco, L., Rowell, J., Huettner, S., Rothman, R. E., Butz, A. M., et al. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001221 · Cited by 11

Rabeprazole inhibits several functions of Entamoeba histolytica related with its virulence

Martínez-Pérez, Y., Néquiz, M., García‐Torres, I., Gudiño‐Zayas, M., López‐Velázquez, G., Enríquez‐Flores, S., Mendoza, E., Saavedra, E., Pérez-Tamayo, R., León-Ávila, G., et al. (2020) · Parasitology Research · doi:10.1007/s00436-020-06868-0 · Cited by 11

Metronidazole—An Old Drug for Structure Optimization and Repurposing

Suvarna, V., Murahari, M., & Pawar, S. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202403389 · Cited by 10

Recalcitrant vaginal trichomoniasis

Pattman, R. S. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.2.127 · Cited by 10

An Improved Method for in Vitro Susceptibility Testing of Trichomonas Vaginalis

Bromke, B. J., Furiga, M. C., Hendershot, R., & McGinn, M. (1995) · Springer eBooks · doi:10.1007/978-1-4757-9203-4_18 · Cited by 9

Pharmacokinetics of Tinidazole in Chinese subjects: Comparison of Mongolian, Korean, Hui, Uighur and Han nationalities

Chang, X., Guo, T., & Dong-ya, X. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3kk50 · Cited by 8

Metronidazol: una visión integral

Bendesky, A., & Menéndez, D. (2001) · Cited by 7

Direct nano-electrospray ionization tandem mass spectrometry for the quantification and identification of metronidazole in its dosage form and human urine

Amer, S., Zarad, W., El-Gendy, H., Salam, R. A. A., Hadad, G. M., Masujima, T., & Emara, S. (2019) · Royal Society Open Science · doi:10.1098/rsos.191336 · Cited by 7

Managing resistant Trichomonas vaginitis

Nyirjesy, P. (1999) · Current Infectious Disease Reports · doi:10.1007/s11908-999-0047-x · Cited by 5

Trichomonal vaginitis refractory to treatment: case report.

Sprott, M. S., Kearns, A., & Pattman, R. S. (1988) · Sexually Transmitted Infections · doi:10.1136/sti.64.6.369 · Cited by 5

Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro

Lepczyńska, M., Dzika, E., Chen, W., & Lu, C. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000325 · Cited by 4

Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department

Sheele, J. M., Morris, N. J., Byars, D., & Counselman, F. L. (2017) · Indian Journal of Sexually Transmitted Diseases and AIDS · doi:10.4103/0253-7184.203438 · Cited by 3

Inhibitory effects of Melia azedarach L. extracts on the growth of Trichomonas vaginalis : Ultrastructural changes of Trichomonas vaginalis treated by Melia azedarach L

Lee, Y. S., Chung, I. B., Choi, W. H., Cho, Y. J., Chu, J. P., Min, B.-I., & Shin, E. (2007) · Obihiro University of Agriculture and Veterinary Medicine Institutional Repository · Cited by 1

Synthesis of novel thiazolobenzimidazoles

Coulbali, S., Zoakouma, R. S. P., Akpa, S. J., Say, V. M., Bamba, F., Sissouma, D., & Adjou, A. (2017) · International Journal of Biological and Chemical Sciences · doi:10.4314/ijbcs.v11i3.32 · Cited by 1

Tinidazole

Grayson, M. (2010) · CRC Press eBooks · doi:10.1201/b13787-104 · Cited by 1

Trichomonas

Bassiouni, S. O. E., & Abdel-Shafi, I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00036-7

POCHODNE BENZIMIDAZOLU WYKAZUJĄCE AKTYWNOŚĆ BIOLOGICZNĄ

Kózka, B., & Kowalkowska, A. (2017) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.72

Trichomonas vaginalis Research: Future directions, opportunities, and challenges

Dwivedi, M., Mondal, S., & Kumar, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22204-7.00015-0

Estudo dos mecanismos moleculares envolvidos na liberação de armadilhas extracelulares neutrofílicas (NETs) em resposta a infecção in vitro por Toxoplasma gondii e seu papel no controle da carga parasitária

Macedo, I. S. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Formulations multifonctionnelles pour le traitement des infections parasitaires cutanéo-muqueuses

Malli, S. (2019) · theses.fr (ABES) · doi:10.70675/f53039e0zde99z48ecz9b9czd36b588f9406

Isolation of Trichomonas vaginalis and Investigation of Metronidazole Susceptibility in Patients with Vaginal Discharge

Çalışkantürk, G., Ekşi, F., & Karuserci, Ö. K. (2023) · ICONTECH INTERNATIONAL JOURNAL · doi:10.5281/zenodo.10636760

Strain of Trichomonas vaginalis Resistant to Metronidazole and Other 5-Nitroimidazoles

Meingassner, J. G., & Thurner, J. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.2.254 · Cited by 148

In vitro Susceptibility of Trichomonas vaginalis to Metronidazole and Treatment Outcome in Vaginal Trichomoniasis

Müller, M., Lossick, J. G., & Gorrell, T. E. (1988) · Sexually Transmitted Diseases · doi:10.1097/00007435-198801000-00004 · Cited by 100

In Vitro Susceptibility of Iranian Isolates of Trichomonas vaginalis to Metronidazole.

Matini, M., Maghsood, A. H., Mohebali, M., Rabiee, S., Fallah, M., Rezaie, S., & Rezaeian, M. (2016) · Europe PMC (PubMed Central) · Cited by 19

In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis

Narcisi, E. M., & Secor, W. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1121 · Cited by 116